Nigerian Pharmaceutical Manufacturing – Essential Medicines Production

Requirement

A greenfield pharmaceutical manufacturing facility in Nigeria seeks $32 million for construction and WHO prequalification. The facility targets production of essential medicines for the Nigerian market and regional export. Production capabilities include solid dosage forms (tablets, capsules), liquid preparations, and injectable medicines. The facility is designed to WHO cGMP standards with WHO prequalification as a key milestone enabling access to international procurement. We seek pharmaceutical industry investors, impact funds focused on healthcare, and development finance institutions. Nigeria imports 70% of pharmaceutical products, creating massive import substitution opportunity with appropriate local manufacturing. The project benefits from Nigeria's pharmaceutical incentives including pioneer status tax holiday, import duty exemptions on equipment, and preferential government procurement. Experienced management team from established African pharmaceutical operations. Target returns of 25-30% IRR with 7-year investment horizon. Construction timeline is 30 months with WHO prequalification targeted 18 months post-commissioning.